← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 1998Last known activity
Sep 9, 2024
Timeline
1990s
- Jun 1, 1997
Ergomed— Founded
2010s
- May 25, 2016
Haemostatix Ltd— Acquired
- Sep 28, 2017
PSR Group B.V.— Acquired
2020s
- Dec 14, 2020
MedSource— Acquired
Drugs by trial phase (17 distinct, 18 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (4 own, 1 via acquisition)
Phase 2 (5 own, 5 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Subsidiaries (3 direct, 3 total across the full acquisition tree)
Recent trials (13)
- NCT06920771CollaboratorPhase 3Sep 9, 2024
- NCT05910450CollaboratorPhase 3Jun 30, 2023
- NCT05914805CollaboratorPhase 3Jun 30, 2023
- NCT05377554CollaboratorPhase 3Apr 29, 2022
- NCT04744207CollaboratorPhase 2Dec 29, 2020
- NCT03697265CollaboratorPhase 2Apr 20, 2018
- NCT02515838CollaboratorPhase 2Jul 1, 2015
- NCT03038828CollaboratorPhase 1Apr 1, 2015
- NCT01918956CollaboratorPhase 4Sep 1, 2013
- NCT01433523CollaboratorPhase 3Aug 1, 2011
- NCT01425788CollaboratorPhase 2Aug 1, 2011
- NCT00496457CollaboratorPhase 2May 1, 2007
- NCT00977483CollaboratorPhase 3May 1, 1998
Details
- Founded
- Guildford, Surrey, GB Jun 1, 1997
- Last known activity
- Sep 9, 2024